Lungpacer Medical Announces Premarket Approval for AeroPace® System
05 déc. 2024 09h00 HE
|
Lungpacer Medical USA Inc.
EXTON, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Lungpacer Medical, a neurostimulation company dedicated to developing innovative interventional therapies to free patients from mechanical ventilation...
Lungpacer Medical Announces PMA Submission for AeroPace® System
04 sept. 2024 09h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System
14 févr. 2022 11h49 HE
|
Lungpacer Medical USA Inc.
EXTON, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a next generation product,...